
Taro Pharmaceutical Industries Ltd.
TARO
TARO: Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.
moreShow TARO Financials
Recent trades of TARO by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by TARO's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on TARO's company Twitter account
Number of mentions of TARO in WallStreetBets Daily Discussion
Recent insights relating to TARO
Recent picks made for TARO stock on CNBC
ETFs with the largest estimated holdings in TARO
Flights by private jets registered to TARO